Atlas FDA

RelayPro Thoracic Stent-Graft System

FDA premarket approval P200045/S002 · decided 2023-03-07

Approval details

PMA number
P200045
Supplement
S002
Supplement type
Panel Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
RelayPro Thoracic Stent-Graft System
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
Bolton Medical, Inc.
Date received
2022-05-16
Decision date
2023-03-07
Days to decision
295 days
Decision code
APPR
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Sunrise, FL
Statement
Approval of the RelayPro Thoracic Stent Graft System for treatment of all lesions of the descending thoracic aorta. The RelayPro Thoracic Stent-Graft System is indicated for the endovascular repair of all lesions of the descending thoracic aorta in patients having appropriate anatomy, including:1) Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories;2) Non-aneurysmal aortic neck diameter in the range of 20 to 42 mm (fusiform an

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
BOLTON PTA CATHETER (K021996)Bolton Medical, Inc.2002-08-23